Short Summary
Union Electric seeks Director Review of the PTAB’s denial to institute an IPR on a mercury‑control patent. BirchTech’s response argues the Director’s decision is final, the litigation history does not merit reversal, and procedural requests are untimely. The Board is asked to deny the review.
Detailed Summary
In IPR2025-01117, Union Electric Company filed a request for Director Review after the PTAB Director denied institution of an inter partes review concerning U.S. Patent No. 10,596,517, which covers mercury emission control technologies for coal‑fired power plants. BirchTech Corp., the patent owner, submitted an authorized response asserting that the Director’s decision is final and non‑appealable under 35 U.S.C. §314(d), that the patent’s prior litigation does not create a basis for reversal, and that the petitioner’s public‑policy, joinder, and stay arguments are procedurally deficient. The response cites numerous cases and statutes to support denial of the review request, and it urges the Board to uphold the Director’s original denial.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in UNION ELECTRIC COMPANY et al. vs MES, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
AMAZON.COM, INC. et al.vsNokia Technologies Oy
Nokia has filed a Director Review request asking the PTAB to vacate its decision to institute an IPR against Amazon's video‑coding patent. The petition argues the Board misapplied the POSITA standard and ignored the inventor's "skip coding mode" terminology.
Google LLCvsCellular South Inc
Google petitions the PTAB Director to overturn a denial of institution for its IPRs, arguing the USPTO’s “settled expectations” rule violates the APA, AIA, and due‑process rights.
Capital One, N.A. et al.vsWapp Tech Corp. et al.
Capital One seeks PTAB Director Review of its IPR against Wapp Tech, with a brief response window for the patent owner.
Tempus AI, Inc.vsGuardant Health Inc.
Guardant Health settled its digital sequencing patent dispute with Foundation Medicine for $25 million plus royalties, granting a non‑exclusive license and dismissing all related litigation.
BOE Technology Group Co., Ltd.vsSamsung Display Co., Ltd.
BOE and Samsung jointly filed a request to keep their IPR settlement agreement confidential and separate from the patent record.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.